| Symposium 9: IBD |
- The 2026 IBD Decision Playbook
In light of the changing landscape of biologics; how to choose the best agent - a guide that clinician can use on Monday morning
- Treat-to-Target:When Guidelines Meet Constraints
Biomakrers, endoscopy, IUS - what to use, what to skip, and how to adapt ACG/BSG target in Asian practice
- When Context Changes the Decision
IBD care across pregnancy, ageing, infection, risk, cost and access - Adapting decisions to real-world Asian constraints
- Immune Checkpoint Inhibitor Colitis: When IBD Rules Don't Apply
ICI management - practical gudie to recognizing, diagnosing and managing ICI colitis
|
|
Tea Symposium
|
| Symposium 10: Nutrition / Microbiome |
- Hocus Pocus in IBS dietary management
- Dietary intervention for metabolic condition
- Microbiome modulation for immunotherapy or chemotherapy augmentation
- Microbiome post bariatric surgery
- Q&A
|
|
Lunch Symposium
|
| Symposium 11: Pancreatobiliary |
- Approach to Biliary Strictures: 2026
- AI in ERCP/Cholangioscopy
- EUS Guided Bilianry Drainage
- EUS Guideed Vascular Intervention
- Q&A
|
|
Tea Symposium
|
| Symposium 12: Endoscopy |
- Premalignant gastric conditions – guidelines from the East to the West Practical tips on what I’m supposed to do in Singapore
- Should I use AI for my colonoscopies? – Comparing consensus from different continents
- Endoscopy in a Warming World: Designing Climate Responsible Practice
- Q&A
|